PRCenter

This is the information on various corporate activities.


Cure Bio Acquisition…Full-scale development of new drugs based on ARS platform

관리자 2018-12-03 17:52:12 Hit 538
File(0)첨부파일 보기

[ 관련기사 ]


https://www.mk.co.kr/news/stock/view/2018/12/754691/

List
Prev
NDFOS, Diversification of business partners…Last year\'s 4Q peak performance
Next
NDFOS, Shareholders\' Refunded Cash and Share Dividend News ↑


arrow TOP